Categories
Change Password!
Reset Password!
A comprehensive multidisciplinary framework optimizes pediatric headache management by integrating bio-behavioral interventions with clinical precision to enhance school performance and global well-being.
A pivotal brief report detailed the evolving landscape of pediatric headache care. The study identified primary pediatric headaches as a massive public health burden, with a prevalence rate exceeding 60%. These conditions were recognized as complex biopsychosocial disorders that significantly impaired school attendance, quality of life (QoL), and family dynamics.
These headaches were characterized as complex biopsychosocial conditions. The review explored recent literature, the International Classification of Headache Disorders 3rd edition (ICHD-3) classification criteria, and consensus guidelines from the American Academy of Neurology (AAN) and the American Headache Society (AHS). It focused particularly on migraine and tension-type headache in adolescents and children.
A significant bidirectional comorbidity was highlighted between headaches and neurodevelopmental disorders. Attention-deficit/hyperactivity disorder (ADHD), learning disabilities, alongside mood disorders like anxiety and depression, were one of them. Clinical evidence suggested these links were likely mediated by shared neurotransmitter dysregulation. Diagnostic processes remained fundamentally clinical, relying on meticulous history taking and the exclusion of "red flags" to rule out secondary etiologies.
Regarding treatment, the therapeutic paradigm emphasized a "bio-behavioral first" approach. This transition followed evidence from the Childhood and Adolescent Migraine Prevention (CHAMP) study, which showed high placebo response rates in prophylaxis trials. Acute management continued to rely primarily on non-steroidal anti-inflammatory drugs (NSAIDs) and triptans, with anti-calcitonin gene-related peptide (CGRP) therapies emerging as a potential treatment option for difficult-to-treat cases.
Ultimately, the report confirmed that a multidisciplinary approach was more effective than single-modality treatment. This multifaceted approach combined lifestyle modification, cognitive behavioral therapy (CBT), biofeedback, and judicious pharmacotherapy to optimize patient outcomes. By addressing the condition through complementary strategies, it reduced disability, improved overall functioning, and helped prevent chronification.
Naunyn-Schmiedeberg's Archives of Pharmacology
Multidisciplinary management of headache in developmental age: effects on school performance, quality of life, and therapeutic perspectives
Francesco Ferrara et al.
Comments (0)